Lin Ping-Yi, Tsai Ching-Tsan, Chuang Wan-Ling, Chao Ya-Hsuan, Pan I-Horng, Chen Yu-Kuo, Lin Chi-Chen, Wang Bing-Yen
Transplant Medicine & Surgery Research Centre, Changhua Christian Hospital, Changhua, Taiwan.
Department of Medical Research, China Medical University Hospital, Taichung, Taiwan.
BMC Complement Altern Med. 2017 Feb 1;17(1):88. doi: 10.1186/s12906-017-1611-9.
Lung cancer is one of the leading causes of cancer related deaths worldwide. Marine microalgae are a source of biologically active compounds and are widely consumed as a nutritional supplement in East Asian countries. It has been reported that Chlorella or Chlorella extracts have various beneficial pharmacological compounds that modulate immune responses; however, no studies have investigated the anti-cancer effects of Chlorella sorokiniana (CS) on non-small cell lung cancer (NSCLC).
In this study, we evaluated the anti-cancer effects of CS in two human NSCLC cell lines (A549 and CL1-5 human lung adenocarcinoma cells), and its effects on tumor growth in a subcutaneous xenograft tumor model. We also investigated the possible molecular mechanisms governing the pharmacological function of CS.
Our results showed that exposure of the two cell lines to CS resulted in a concentration-dependent reduction in cell viability. In addition, the percentage of apoptotic cells increased in a dose-dependent manner, suggesting that CS might induce apoptosis in human NSCLC cells. Western blot analysis revealed that exposure to CS resulted in increased protein expression of the cleaved/activated forms of caspase-3, caspase-9, and PARP, except caspase-8. ZDEVD (caspase-3 inhibitor) and Z-LEHD (caspase-9 inhibitor) were sufficient at preventing apoptosis in both A549 and CL1-5 cells, proving that CS induced cell death via the mitochondria-mediated apoptotic pathway. Exposure of A549 and CL1-5 cells to CS for 24 h resulted in decreased expression of Bcl-2 protein and increased expression of Bax protein as well as decreased expression of two IAP family proteins, survivin and XIAP.
We demonstrated that CS induces mitochondrial-mediated apoptosis in NSCLC cells via downregulation of Bcl-2, XIAP and survivin. In addition, we also found that the tumors growth of subcutaneous xenograft in vivo was markedly inhibited after oral intake of CS.
肺癌是全球癌症相关死亡的主要原因之一。海洋微藻是生物活性化合物的来源,在东亚国家被广泛用作营养补充剂。据报道,小球藻或小球藻提取物含有多种有益的药理化合物,可调节免疫反应;然而,尚无研究调查索氏小球藻(CS)对非小细胞肺癌(NSCLC)的抗癌作用。
在本研究中,我们评估了CS对两种人NSCLC细胞系(A549和CL1-5人肺腺癌细胞)的抗癌作用,以及其对皮下异种移植肿瘤模型中肿瘤生长的影响。我们还研究了CS药理功能的潜在分子机制。
我们的结果表明,两种细胞系暴露于CS后,细胞活力呈浓度依赖性降低。此外,凋亡细胞的百分比呈剂量依赖性增加,表明CS可能诱导人NSCLC细胞凋亡。蛋白质印迹分析显示,暴露于CS导致caspase-3、caspase-9和PARP的裂解/活化形式的蛋白质表达增加,但caspase-8除外。ZDEVD(caspase-3抑制剂)和Z-LEHD(caspase-9抑制剂)足以预防A549和CL1-5细胞的凋亡,证明CS通过线粒体介导的凋亡途径诱导细胞死亡。A549和CL1-5细胞暴露于CS 24小时后,Bcl-2蛋白表达降低,Bax蛋白表达增加,同时两种IAP家族蛋白survivin和XIAP的表达降低。
我们证明CS通过下调Bcl-2、XIAP和survivin诱导NSCLC细胞发生线粒体介导的凋亡。此外,我们还发现口服CS后,体内皮下异种移植肿瘤的生长明显受到抑制。